- Q1 2024 Editas Medicine Inc Earnings Call TranscriptMay 08, 2024$5.04 (-11.36%)Earnings
- Q4 2023 Editas Medicine Inc Earnings Call TranscriptFeb 28, 2024$11.07 (+24.94%)Earnings
- Editas Medicine Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Q3 2023 Editas Medicine Inc Earnings Call TranscriptNov 03, 2023$8.31 (+18.21%)Earnings
- Editas Medicine Inc at JPMorgan Biotech Fireside Investor Series TranscriptOct 12, 2023
- Editas Medicine Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Editas Medicine Inc at Wells Fargo Healthcare Conference TranscriptSep 07, 2023
- Q2 2023 Editas Medicine Inc Earnings Call TranscriptAug 02, 2023$9.14 (+5.66%)Earnings
- Editas Medicine Inc RUBY trial of EDIT-301 TranscriptJun 12, 2023
- Editas Medicine Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Editas Medicine Inc Earnings Call TranscriptMay 05, 2023$9.77 (+12.04%)Earnings
- Q4 2022 Editas Medicine Inc Earnings Call TranscriptFeb 22, 2023$9.75 (+6.21%)Earnings
- Editas Medicine Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Editas Medicine Inc EDIT-301 Clinical Update TranscriptDec 06, 2022
- Editas Medicine Inc Announces EDIT-101 Clinical Update Presentation TranscriptNov 17, 2022
- Q3 2022 Editas Medicine Inc Earnings Call TranscriptNov 02, 2022$12.89 (+1.10%)Earnings
- Editas Medicine Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 Editas Medicine Inc Earnings Call TranscriptAug 03, 2022$18.69 (+13.41%)Earnings
- Q1 2022 Editas Medicine Inc Earnings Call TranscriptMay 04, 2022$15.81 (+11.50%)Earnings
- Q4 2021 Editas Medicine Inc Earnings Call TranscriptFeb 24, 2022$15.86 (+10.06%)Earnings
- Editas Medicine Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- Editas Medicine Inc at Barclays Gene Editing & Gene Therapy Summit (Virtual) TranscriptNov 15, 2021
- Q3 2021 Editas Medicine Inc Earnings Call TranscriptNov 08, 2021$40.57 (+8.19%)Earnings
- Editas Medicine Inc EDIT-101 Clinical Data Review Call TranscriptSep 29, 2021
- Editas Medicine Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
- Q2 2021 Editas Medicine Inc Earnings Call TranscriptAug 04, 2021$46.05 (+9.36%)Earnings
- Editas Medicine Inc Annual Shareholders Meeting TranscriptJun 03, 2021
- Q1 2021 Editas Medicine Inc Earnings Call TranscriptMay 05, 2021$34.72 (+0.17%)Earnings
- Editas Medicine Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 10, 2021
- Q4 2020 Editas Medicine Inc Earnings Call TranscriptFeb 25, 2021$44.76 (-9.94%)Earnings
- Editas Medicine Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Editas Medicine Inc at Barclays Virtual Gene Editing & Gene Therapy Summit TranscriptNov 16, 2020
- Q3 2020 Editas Medicine Inc Earnings Call TranscriptNov 05, 2020$31.55 (+3.61%)Earnings
- Editas Medicine Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2020
- Q2 2020 Editas Medicine Inc Earnings Call TranscriptAug 06, 2020$36.84 (+13.39%)Earnings
- Editas Medicine Inc Annual Shareholders Meeting TranscriptJun 10, 2020
- Q1 2020 Editas Medicine Inc Earnings Call TranscriptMay 07, 2020$24.1 (-3.64%)Earnings
- Q4 2019 Editas Medicine Inc Earnings Call TranscriptFeb 26, 2020$22.41 (-0.31%)Earnings
- Editas Medicine Inc at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Q3 2019 Editas Medicine Inc Earnings Call TranscriptNov 12, 2019$22.32 (+9.47%)Earnings
- Editas Medicine Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Editas Medicine Inc, Apellis Pharmaceuticals Inc and Rigel Pharmaceuticals Inc at Citi Biotech Conference TranscriptSep 05, 2019
- Q2 2019 Editas Medicine Inc Earnings Call TranscriptAug 06, 2019$24.63 (+2.93%)Earnings
- Q1 2019 Editas Medicine Inc Earnings Call TranscriptMay 07, 2019$24.68 (-4.56%)Earnings
- Editas Medicine Inc at Barclays Global Healthcare Conference TranscriptMar 14, 2019
- Q4 2018 Editas Medicine Inc Earnings Call TranscriptFeb 28, 2019$20.63 (-1.53%)Earnings
Editas Medicine Inc at Morgan Stanley Global Healthcare Conference Transcript
Great. Well, good morning, everybody. Thanks for joining us for the next session. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. Very pleased to have Editas with us for the next session. Just briefly, before we get started, I need to read a quick disclosure statement. Please note that all important disclosures, including personal holdings disclosures are available at the Morgan Stanley public website at morganstanley.com/research disclosures. Now with that excitement out of the way, we can get down to the real business. So really pleased to have the team here with us.
Questions & Answers
I thought maybe a nice place to start is just, there's so much innovation in gene editing going on. And I think from an investor standpoint, there's a lot of different modalities now in gene editing. So can you talk a little bit about how you think about your underlying technology
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)